Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
NRGX Gene therapy
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by BooDog: [QB] http://finance.yahoo.com/q/pr?s=NRGX.OB http://clinicaltrials.gov/ct2/show/NCT00643890?term=neurologix&rank=1 Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease This study is currently recruiting participants. Verified by Neurologix, Inc., November 2008 Sponsored by: Neurologix, Inc. Information provided by: Neurologix, Inc. ClinicalTrials.gov Identifier: NCT00643890 Purpose The purpose of this study is to determine the safety and efficacy of AAV-GAD gene transfer into the subthalamic nucleus (STN) region of the brain. This study involves the treatment of patients with medically refractory Parkinson's disease (PD). The gene transfer product, a disabled virus with a gene called GAD, will be infused into the STN bilaterally using stereotactic surgical techniques. The overall goal of this approach is to normalize the activity of the STN and reduce the motor symptoms of PD. Condition Intervention Phase Parkinson's Disease Genetic: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus Phase II NEUROLOGIX INC(OTC BB: NRGX.OB) Last Trade: 0.50 Trade Time: Nov 11 Change: 0.00 (0.00%) Prev Close: 0.50 Open: N/A Bid: 0.28 x 5000 Ask: 0.56 x 2500 1y Target Est: 2.00 Day's Range: N/A - N/A 52wk Range: 0.45 - 1.39 Volume: 0 Avg Vol (3m): 9,637.5 Market Cap: 13.88M P/E (ttm): N/A EPS (ttm): -0.55 Div & Yield VERY LOW VOLUME. 52 wk low is wrong. Recent lows are .27 and .28 [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2